ArticleBlood neoplasia2025

V-FAST: a phase 1b master trial to investigate CPX-351 combined with targeted agents in adults with newly diagnosed AML.

Vinod A Pullarkat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.